Neither medication is currently available in Canada through traditional channels, though Mazdutide has already received regulatory approval in China and sits closer to global market availability
And at higher doses , the math scales linearly
Gaucher, a rare disease affecting about one in every 50,000 people in the world population and up to one in 500 people in people of Ashkenazi (eastern and central European) Jewish heritage
William Kennedy elaborates on what this authorization could look like, "When insurers ask for proof of 'prior weight-loss attempts' as part of the prior-authorization process for GLP-1 medications, what theyre really looking for are structured, sustained efforts
Evidence that TSH receptor a-subunit multimers, not monomers, drive antibody affinity maturation in Graves disease
ACS Nano 17 , 1379213810 (2023)